Photo: Ben Ho Park
Ben Ho Park
Year elected: 2018
Current membership category: Active
Cornelius Abernathy Craig Chair, Director, Division of Heme/Onc, Deputy Director and Director of Precision Oncology, Vanderbilt-Ingram Cancer Center
Vanderbilt University Medical Center
2220 Pierce Avenue
PRB 777
Nashville, TN 37232
United States of America
Phone: 6159361919

Biographical statement

Dr. Park attended The University of Chicago for his A.B. degree, followed by dual training at The University of Pennsylvania School of Medicine where he received both his M.D. and Ph.D. degrees. Dr. Park then trained in Internal Medicine and Hematology/Oncology at The University of Pennsylvania prior to completing a post-doctoral fellowship in the laboratory of Dr. Bert Vogelstein at Johns Hopkins. Dr. Park then joined the faculty at The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and was Professor of Oncology, Associate Director of Education and Research Training and Associate Dean of Postdoctoral Affairs for the School of Medicine prior to joining Vanderbilt University Medical Center in 2018. He is currently the Cornelius Abernathy Craig Chair and Director, Division of Heme/Onc, and Deputy Director and Director of Precision Oncology for the Vanderbilt-Ingram Cancer Center. His research program involves identifying and validating genetic targets for breast cancer therapy and diagnostics. In particular, Dr. Park has pioneered the use of “liquid biopsies” to help guide future management of breast cancer therapies. He has also led the formation and implementation of molecular tumor boards at Hopkins and other institutions, and more recently at the Vanderbilt-Ingram Cancer Center.

Institutional affiliations

Christopher S. Williams, MD, PhD is the representative at this institution.


Breast cancer
Medical Oncology